| 发明名称 |
Hemophilia treatment by inhalation of coagulation factors |
| 摘要 |
Hemophilia treatment by the inhalation of coagulation factors. Dry powder Factor IX is aerosolized to a mass median aerodynamic diameter of 4 mum or less, with at least 90% monomer content, at least 80% activity level, and 10% water or less. The aerosol is slowly, and deeply inhaled into the lung, and followed by a maximal exhale.
|
| 申请公布号 |
US2005008580(A1) |
申请公布日期 |
2005.01.13 |
| 申请号 |
US20040820656 |
申请日期 |
2004.04.08 |
| 申请人 |
WYETH;NEKTAR THERAPEUTICS |
发明人 |
GONG DAVID K.;HASTEDT JAYNE E.;SCHAUB ROBERT G.;WARNE NICHOLAS W.;DORNER ANDREW J.;WEBB CHANDRA A.;KEITH JAMES C. |
| 分类号 |
A61J3/02;A61K;A61K9/12;A61K38/00;A61K38/37;A61L9/04;(IPC1-7):A61L9/04 |
主分类号 |
A61J3/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
